通过激活Nrf2/TrxR1通路,PSMD12促进非小细胞肺癌的进展
Junqi Lv1, Shengmao Ma2, Xiaowen Wang2
1Department of Thoracic Surgery, People's Hospital of Ningxia Hui Autonomous Region, No. 301, Zhengyuan North Street, Yinchuan, Ningxia, People's Republic of China. ljqi10358@126.com.
Genes & genomics
|January 19, 2024
概括
蛋白酶26S亚基,非ATPase12 (PSMD12) 通过激活Nrf2/TrxR1通路,驱动非小细胞肺癌 (NSCLC) 的进展. 这一发现将PSMD12确定为NSCLC治疗的潜在治疗标.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 非小细胞肺癌 (NSCLC) 是癌症死亡的主要原因.
- 蛋白酶26S子单元,非ATPase 12 (PSMD12) 在NSCLC病变发生过程中的作用在很大程度上是未知的.
- PSMD12与其他癌症的瘤促进有关.
研究的目的:
- 研究PSMD12在NSCLC中的功能性作用.
- 阐明PSMD12在NSCLC中的作用背后的分子机制.
- 评估PSMD12作为NSCLC的潜在治疗点.
主要方法:
- 定量实时PCR (qRT-PCR) 和西式涂抹来评估PSMD12表达.
- 细胞活力,增殖,亡,迁移和入侵试验用于评估NSCLC细胞行为.
- 双化酶测定以确认转录因子活性.
主要成果:
- 在NSCLC组织和细胞系中,PSMD12的表达被上调.
- 镇压PSMD12抑制NSCLC细胞的生长,迁移和入侵.
- PSMD12通过Nrf2/TrxR1通路促进NSCLC的进展,通过增加Nrf2蛋白水平和核转位,导致增强TrxR1转录.
结论:
- PSMD12显著促进NSCLC的进展.
- Nrf2/TrxR1信号通路是PSMD12致癌功能的关键调解者.
- PSMD12代表了NSCLC的一个有前途的预后和治疗标.
相关概念视频
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
MAPK Signaling Cascades
5.5K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.5K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
NF-κB-dependent Signaling Pathway
7.4K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.4K
Electron Transport Chain: Complex I and II
13.4K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
13.4K


